Valuation: Vineet Laboratories Limited

Market Cap 558M 5.86M 5.12M 4.71M 4.39M 8.33M 8.45M 56.54M 21.98M 274M 22M 21.53M 945M P/E 2024
43.6x
P/E 2025 -1.42x
Enterprise Value 956M 10.04M 8.77M 8.06M 7.52M 14.25M 14.47M 96.79M 37.63M 470M 37.67M 36.86M 1.62B EV / Sales 2024
587,502x
EV / Sales 2025 890,202x
Free-Float
62.66%
Yield 2024 *
-
Yield 2025 -
1 day+0.09%
1 week-1.03%
Current month-0.47%
1 month-2.15%
3 months+14.03%
6 months-2.21%
Current year-8.51%
1 week 32.5
Extreme 32.5
34.6
1 month 32.5
Extreme 32.5
35.79
Current year 27.96
Extreme 27.96
43.5
1 year 27.96
Extreme 27.96
49.99
3 years 26.51
Extreme 26.51
88.9
5 years 26.51
Extreme 26.51
124
10 years 26.51
Extreme 26.51
124
Manager TitleAgeSince
Chief Executive Officer 56 09/11/2016
Director of Finance/CFO 76 31/12/2020
Human Resources Officer - -
Director TitleAgeSince
Director/Board Member 56 09/11/2016
Director/Board Member 76 09/11/2016
Director/Board Member 52 -
Change 5-day change 1-year change 3-year change Capi.($)
+0.09%-1.03%+1.54%-35.97% 6.78M
+1.86%+0.48%+55.50%+163.08% 1,082B
+3.57%+3.29%+68.60%+61.03% 633B
+3.99%+3.05%+37.93%+93.37% 461B
+3.86%+1.64%+32.57%+24.89% 339B
-0.56%+0.96%+41.67%+39.35% 301B
-0.08%+1.30%+32.15%+44.48% 292B
-1.54%+2.81%-25.35%-39.61% 225B
+3.55%+4.41%+25.45%+66.28% 202B
+4.21%+2.65%+17.47%+71.11% 163B
Average +1.90%+4.02%+28.75%+48.80% 369.97B
Weighted average by Cap. +2.24%+5.52%+42.24%+83.14%

Financials

2024 2025
Net sales 1.51K 15.86 13.86 12.74 11.87 22.52 22.86 152.92 59.45 742.07 59.51 58.24 2.56K 769.53 8.08 7.07 6.49 6.05 11.48 11.65 77.95 30.3 378.26 30.34 29.69 1.3K
Net income 10.27M 108K 94.3K 86.66K 80.78K 153K 156K 1.04M 404K 5.05M 405K 396K 17.4M -202M -2.12M -1.85M -1.7M -1.59M -3.01M -3.06M -20.45M -7.95M -99.25M -7.96M -7.79M -342M
Net Debt 441M 4.63M 4.05M 3.72M 3.47M 6.57M 6.67M 44.64M 17.35M 217M 17.37M 17M 747M 397M 4.17M 3.65M 3.35M 3.13M 5.93M 6.02M 40.26M 15.65M 195M 15.67M 15.33M 673M
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
03/07/26 ₹33.65 +0.09% 5,510
02/07/26 ₹33.62 +1.08% 11,357
01/07/26 ₹33.26 -1.63% 9,171
30/06/26 ₹33.81 +1.41% 27,486
29/06/26 ₹33.34 -1.94% 58,192
  1. Stock Market
  2. Stocks
  3. VINEETLAB Stock